February 1, 2012

As part of DSN's Executive Retailer Viewpoint series, DSN sat down with Jason Reiser, VP health and wellness, ops/compliance at Sam's Club, at DSN's Industry Issues Summit to discuss how to better engage customers and the impact of the economy on business in 2012.

January 18, 2012

In an effort to tap into the minds of some of the industry's top executives, Drug Store News recently sat down and talked with some of these leaders in a multipart executive viewpoint video series.

July 29, 2015

Patients were unable to follow approprate treatment protocols for an OTC Lipitor, so Pfizer decided to discountinue its switch application. 

July 15, 2015

Pfizer and the Arthritis Foundation will work togeher on developing educational tools in support of arthritis. 

July 15, 2015

The new guidelines have been expected to increase the number of statin-eligible adults by almost 13 million.

June 29, 2015

Tris Pharma will supply the new Robitussin long-acting dextromethorphan. 

June 23, 2015

Pfizer has entered into an agreement with GlaxoSmithKline to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for approximately $130 million.

June 15, 2015

Pfizer Consumer Healthcare in May joined the gummy vitamin lineup with the launch of Centrum MultiGummies, adding the leading multivitamin brand to the number of adult gummy vitamin options on the shelf.

June 2, 2015
Aurobindo Pharma Limited has received approval from the Food and Drug Administration for its generic equivalent to Flagyl (metronidazole) tablets in 250- and 500-mg dosage strengths.  
 
May 29, 2015

The Food and Drug Administration Friday announced that it had approved Rapamune (sirolimus), distributed by Pfizer’s Wyeth Pharmaceuticals, as a treatment for the rare lung disease lymphangioleiomyomatosis (LAM). 

May 14, 2015

Greenstone, a subsidiary of Pfizer, announced the introduction of doxycycline hyclate capsules, USP to its line of generic pharmaceutical products.

April 30, 2015

Pfizer survey finds that consumers reach for OTCs in taking ownership of their own health. 

April 22, 2015

If you were impressed by the recent switches of Nasacort Allergy 24HR, Nexium 24HR or Flonase — well-executed and model switches — well, you ain’t seen nothing yet.

March 4, 2015

Almost half of all circular ads in support of a digestive remedy promote an antacid tablet. 

March 4, 2015

There was a $1.1 billion gain in OTC sales between 2013 and 2014, according to data culled from IRI, some $500 million of which can be attributed to an increase in sales across all cough-cold/allergy/sinus products and an approximate $300 million to a rise in digestive sales.

March 4, 2015

Drug Store News has partnered with Competitive Promotion Report and IRI to create a series of exclusive reports. This edition explores cold/allergy/sinus products in both the liquid/powder and tablets/packets segments.

March 4, 2015

While the big four analgesic manufacturers — Bayer, Pfizer, McNeil and Novartis — command the lion’s share of retail ad support behind their mega analgesic brands, Prestige Brands and BedRock Brands are making headway promoting their niche pain relieving products.

February 27, 2015

Camber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension.

February 26, 2015

Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products. 

 

February 9, 2015

Onco360 on Monday announced that it has been selected by Pfizer as a limited-distribution pharmacy network participant for Ibrance (palbociclib), Pfizer’s recently approved product for certain breast cancers.

February 6, 2015

Prestige Brands will be resuming healthcare professional marketing programs in support of its Monistat vaginal treatments.

February 5, 2015

There is a sharp spike in cough-cold promotion across retail circulars in the back-to-school season, according to an analysis of circular retail promotions provided by ECRM, as moms prepare their families for the inevitable season of sniffles and sneezes with the coming school year.

February 5, 2015

Pfizer has entered into a definitive merger agreement to acquire Hospira.

 

January 26, 2015

NJOY announced the appointment of Paul Sturman as its new CEO and president.